Abstract
Purpose
This study explores the association of the American Society of Anesthesiologists (ASA) score with 90-day mortality in complicated mild traumatic brain injury (mTBI) patients, and in trauma patients without a TBI.
Methods
This retrospective study was conducted using a cohort of trauma patients treated at a level III trauma center in Stockholm, Sweden from January to December 2019. The primary endpoint was 90-day mortality. The population was identified using the Swedish Trauma registry. The Trauma and Injury Severity Score (TRISS) was used to estimate the likelihood of survival. Trauma patients without TBI (NTBI) were used for comparison. Data analysis was conducted using R software, and statistical analysis included univariate and multivariate logistic regression.
Results
A total of 244 TBI patients and 579 NTBI patients were included, with a 90-day mortality of 8.2% (n = 20) and 5.4% (n = 21), respectively. Deceased patients in both cohorts were generally older, with greater comorbidities and higher injury severity. Complicated mTBI constituted 97.5% of the TBI group. Age and an ASA score of 3 or higher were independently associated with increased mortality risk in the TBI group, with odds ratios of 1.04 (95% 1.00–1.09) and 3.44 (95% CI 1.10–13.41), respectively. Among NTBI patients, only age remained a significant mortality predictor. TRISS demonstrated limited predictive utility across both cohorts, yet a significant discrepancy was observed between the outcome groups within the NTBI cohort.
Conclusion
This retrospective cohort study highlights a significant association between ASA score and 90-day mortality in elderly patients with complicated mTBI, something that could not be observed in comparative NTBI cohort. These findings suggest the benefit of incorporating ASA score into prognostic models to enhance the accuracy of outcome prediction models in these populations, though further research is warranted.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Mild Traumatic Brain Injury (mTBI) has emerged as a substantial burden on global health systems as it constitutes 60–95% of the 50–60 million TBI cases each year [9, 23]. Traditionally, mTBI is internationally defined as an admission Glasgow Coma Scale (GCS) of 13–15 [44], where some use the term “complicated” mild TBI in cases with radiologically visible intracranial lesions [23]. Outcomes are considered to be generally favorable, and current mild TBI-specific prediction models, such as Corticosteroid Randomization After Significant Head Injury (CRASH) [6], NIMJEN-Rubics [16], UPFRONT [45], and Toronto Rehabilitation Institute Concussion Outcome Determination and Rehab Recommendations (TRICORDRR) score [22], focus on either complete recovery (a Glasgow Outcome Score (GOS) of 5, or an extended GOS of 8) or lingering post-concussion symptoms [26]. Apart from psychiatric conditions, none of these models take pre-injury comorbidities into account and focus solely on trauma specific severity assessments.
As the global population ages, particularly in high-income countries, there's a notable increase in the incidence of mTBI among the elderly, primarily due to falls and other low-energy accidents [13, 23]. Studies have consistently shown that elderly individuals are more susceptible to adverse outcomes following mTBI, such as unfavorable functional outcome and death [4, 30, 37, 39, 41], where frailty and existing comorbidities are believed to be a contributing factor [13, 42, 49]. A common clinical tool used when assessing comorbidities is the American Society of Anesthesiologists (ASA) score. The ASA score is primarily used to assess patients preoperatively, and even though it is hampered some due to interrater variability it is still considered an important tool for risk assessment [25]. Studies indicate that ASA score might be an independent predictor of mortality after trauma [21, 40], however the association is poorly studied in TBI in general and mTBI in particular.
The initial management of mTBI does not usually involve neurosurgical intervention and is primarily handled by emergency physicians or general surgeons. Neurosurgeons are, however, often consulted if there are intracranial lesions, where they are tasked to provide advice in terms of management and outcome prediction of these patients. The Trauma and Injury Severity Score (TRISS), a general trauma prediction model of mortality, has been applied with some success to TBI [29, 47], but its efficacy in mTBI remains untested. Trauma patients without TBI therefore become an intriguing control group for studying the impact of mTBI on patient outcomes.
We previously conducted a prospective follow-up study of a mTBI cohort, where the main outcome metrics where depression and long-term health-related quality of life (HRQoL) [20]. We noted a strong correlation of pre-injury ASA score to outcome, but also a surprisingly high mortality rate in the, per GCS definitions, mTBI cohort, something seen in other studies as well [4, 41]. Mortality is not considered an expected outcome after mTBI which prompted us to explore this further and evaluate if the pre-trauma health status measured with ASA score can predict 90-day mortality post mTBI.
Methods
Study design
The study is a retrospective, single-center cohort study based on a cohort treated for trauma at Södersjukhuset, Stockholm, Sweden, January – December 2019. The hospital is one of several level III trauma centers in Stockholm, serving approximately 700 000 inhabitants. Stockholm also has a level I trauma center with neurosurgical capabilities, and patients with moderate-severe TBI (GCS 3–12) or polytrauma are typically referred there. Relevant baseline data prospectively assembled at the time of admission was retrospectively screened. The research protocol was approved by the Swedish Ethical Review Authority (Dnr: 2019–06122). The primary endpoint is mortality within the first 90-days from trauma.
Population
The Swedish Trauma registry (SweTrau) was used to identify the trauma population. SweTrau, a national trauma registry established in 2011, is based on the revised Utstein Trauma Template [2]. Inclusion criteria for the current study was age ≥ 18 years at the time of injury, a trauma alert activated at hospital or a New Injury Severity Score (NISS) of more than 15, and GCS of 13 or higher. Exclusion criteria were trauma alert activated without underlying trauma, non-traumatic injuries such as asphyxia and hypothermia, death prior to arrival, trauma more than 24 h prior of admission, or missing significant data. In the case of multiple admissions during the set timeframe, only the first was included.
Variables
Demographic data was collected from medical records. GCS at admission was assessed by the attending clinician upon hospital admission. Scoring of Abbreviated Injury Score (AIS) was performed by accredited AIS-scoring professionals according to the stated guidelines. GOS was obtained at discharge from the hospital. Anticoagulants were categorized as low-weight molecular heparin (LMH), direct oral anticoagulants (DOAK), or Warfarin. Antiplatelet medication included Clopidogrel and acetylsalicylic acid.
ASA score
The ASA score has been shown to be a good approximation of comorbidities in trauma patients [33], and was in this study used to categorize illness before injury, according to the international ASA-PS edition, presented by the American Society of Anesthesiologist (supplementary Table 1) [7]. Severe comorbidity was defined as ASA-score ≥ 3.
TBI vs NTBI
The cohort was divided into TBI, defined with the International Classification of Disease, 10th version (ICD-10), with all intracranial lesions and skull fractures classified as TBI (supplementary Table 2), and non-TBI (NTBI) subsequently.
Trauma and Injury Severity Score, TRISS
TRISS is a widely recognized method used to predict the likelihood of survival following a traumatic injury. It combines the Revised Trauma Score (RTS), which includes physiological parameters like respiratory rate, systolic blood pressure, and GCS, with the Injury Severity Score (ISS) and the patient's age [1, 3]. The complete formula is outlined in supplementary Table 3. The result is a statistical model that estimates the probability of survival given the severity and nature of the injuries. This tool is particularly valuable in trauma research and clinical settings for assessing the effectiveness of care and for benchmarking outcomes.
Statistical analysis
All data was analyzed using R [43] through the visual interface R-studio (v. 2022.07.2 Build 576, PBC, USA). Normal distribution was assessed with Shapiro–Wilk test. The results are presented as median with interquartile range for continuous data, and n (%) for nominal data, if not stated otherwise. Baseline characteristics among TBI and NTBI patients were assessed using the Mann–Whitney U test for quantitative variables, chi-squared test for categorical variables with expected count of at least 5, and Fischer’s exact test for categorical variables with expected count of less than 5, and ordered logit for ordinal variables. The significance level was set to 0.05. Univariable logistic regression was used to determine the effect of age, ASA score, and AIS (head) on mortality, and multivariable logistic regression was used to assess independency of ASA score and age.
Results
Demographics
The study included 823 patients, with 244 in the TBI cohort and 579 in the NTBI cohort (Fig. 1). Gender distribution was similar, with 61% males in the TBI group and 57% in the NTBI group (p = 0.4) (Table 1). However, the median age was significantly higher in the TBI cohort (67 years) compared to the NTBI cohort (57 years) (p < 0.001). In terms of ASA scores, 39.4% of the TBI patients had an ASA score of 3 or higher, indicating severe systemic disease, while this was true for only 27% of the NTBI patients. Additionally, 41% of the NTBI cohort was classified as healthy (ASA 1), compared to 32% in the TBI cohort (p = 0.002). No significant difference was found in anticoagulant treatment, 66% of TBI patients and 77% of NTBI patients were not on any anticoagulants (p = 0.052).
Injury characteristics
The mechanism of injury varied significantly between the cohorts (p < 0.001) (Table 1). Low energy falls were the most common mechanism in both groups but were more prevalent in the TBI cohort (59%) compared to the NTBI cohort (38%). Traffic-related injuries were more common in the NTBI group (30%) than in the TBI group (16%).
The TBI cohort had significantly higher injury severity as indicated by NISS (14 vs. 3, p < 0.001) and a slightly higher TRISS. The GCS score was lower in the TBI cohort (p < 0.001), with 66% having a GCS of 15, compared to 89% in the NTBI cohort. Additionally, 97,6% of the TBI patients had a complicated mTBI (AIS head score ≥ 2) (Fig. 2).
Outcome
The median length of hospital stay was longer for TBI patients at 3 days, compared to 2 days for NTBI patients (p < 0.001) (Table 1). The GOS scores indicated worse outcomes for the TBI cohort, with only 1% achieving a GOS of 5 compared to 39% of NTBI patients (p < 0.001). The 90-day mortality rate was 8.2% (20 patients) for the TBI group and 5.4% (31 patients) for the NTBI group (p = 0.2). Deceased NTBI patients were significantly older than deceased TBI patients (86 vs. 77 years, p = 0.043) (Table 2). While ASA scores were similar (p = 0.5), NTBI deceased patients had lower injury severity (NISS 10 vs. 21, p < 0.001) and a lower TRISS (0.993 vs. 0.996, p = 0.001). Mortality timing showed that 55% of deaths in both cohorts occurred within 90 days. In-hospital mortality was 35% for TBI patients and 26% for NTBI patients (p = 0.6).
In the univariable analysis age, an ASA score, or an AIS (head) of 3 or higher, and treatment with anticoagulants were associated with 90-day mortality in the TBI group (Table 3 and Fig. 3). Both age and ASA maintained an independent association for mortality in the multivariable analysis, with odds ratios of 1.04 (1.00–1.09) and 3.44 (1.10–13.41), respectively.
Age, ASA score, and both anticoagulants and antiplatelets were associated with 90-day mortality in the univariable analysis for the NTBI-group, however for the NTBI patients, ASA was not statistically significant in the multivariable analysis (Table 3 and Fig. 3).
TRISS calculations revealed a small but statistically significant difference in predicted survival between the TBI and NTBI groups overall (p < 0.001), as well as within the deceased cohorts (0.996 [95% CI: 0.993–0.997] for TBI vs. 0.993 [95% CI: 0.990–0.993] for NTBI, p < 0.001) (Table 1 and Table 2).
Discussion
This retrospective cohort study highlights a significant association between ASA score and 90-day mortality in patients with complicated mTBI, that is not found in the NTBI cohort.
Mild TBI is typically not associated with high mortality rates. However, our study found a 90-day mortality rate of 8.2% for mTBI patients, compared to 5.4% for NTBI trauma patients, exclusively among the elderly. The high mortality reflects the significant impact of demographic shifts, indicating that complicated mTBI in older adults can no longer be considered "mild." This is illustrated in a 2024 study Orso et al. [31], which reported a seven percent 90-day mortality rate in mTBI patients, with no cases younger than 80 years. This mortality rate is comparable to that seen in elderly hip fracture patients, which ranges from 7.8% to 9.4% [38]. The demographic shift necessitates a re-evaluation of mTBI management, as older adults tend to sustain more severe injuries despite having a similar admission GCS score [41]. Our data supports this, showing that over 97% of mTBI patients had an AIS head score of 2 or more, a level some argue should classify as moderate to severe TBI [36]. Additionally, 68% of our cohort had isolated mTBI, defined by an AIS score below 2 in other body regions.
Although we lack specific data on the causes of death due to limitations of the SweTrau registry, insights can be drawn from similar conditions. Mortality after hip fractures is often attributed to pulmonary infections, myocardial infarction, and sepsis, primarily due to underlying comorbidities and immobilization [18]. Given the similarities in demographics, these factors are likely contributors to mortality in mTBI patients as well. The extensive study by Dolejs and Marešová assessed age-related increases in mortality due to non-traumatic causes in Scandinavian countries, revealing a yearly mortality rate of about 0.05% for individuals aged 18–44, increasing to 0.5% for those aged 65–74, and up to 3% for those 85 and older [10]. Even when compared to the oldest age group, our 90-day mortality rates are significantly higher, highlighting the compounded impact of age and trauma on resilience and outcomes in elderly mTBI patients. This aligns with research indicating that elderly TBI patients have worse mortality and functional outcomes than younger patients with similar injury severity [41], and that pre-existing medical conditions increase mortality risk in elderly trauma patients, especially for minor to moderate injuries [5]. The severity of the TBI likely contributes to our high mortality rate as well, as an AIS head score of 3 or higher was associated with increased mortality, consistent with previous findings [35]. While the TBI itself may not directly cause death (e.g., through herniation or ischemia), its severity can impact factors such as mobilization, leading to indirect detrimental effects like aspiration or embolism.
Our main finding is that ASA score, adjusted for age, was independently associated with mortality. The overall burden of disease that the ASA score encompasses, captures both the impact of comorbidities [33] and functional frailty [25]. The literature on the role of comorbidities in TBI outcomes is conflicted. For instance, Orso et al. found no statistically significant correlation between mortality at 90 days and the presence of specific comorbidities (p-value 0.177) [31]. In a 2021 systematic review by Xiong et al. the authors noted that while the absolute number and presence of comorbidities were significantly associated with long-term mortality (> 1 year), they were not linked to short-term mortality [48]. Conversely, Dell et al. found in a study involving over 20,000 patients, that as the number of pre-existing health conditions increased, the mortality rate after TBI climbed incrementally by a factor of 1.7–1.9, suggesting a clear relationship between comorbidity burden and mortality risk [8]. A recent meta-analysis by Roohollahi found that five out of nine studies investigating the association between frailty and in-hospital mortality after TBI reported a positive association [34]. However, the four studies that did not find frailty to be a significant predictor of in-hospital death had adjusted for age and other variables, complicating the conclusion. The association between ASA score and outcomes after TBI is not well-studied, despite its widespread use in clinical practice. However, its predictive value has been extensively demonstrated in surgical contexts. Hackett et al. reported that the ASA score independently predicts 30-day complication and mortality rates across a wide spectrum of surgical procedures [14]. Specifically, their study found a 30-day mortality rate of 1.41% for patients with an ASA score of 3, increasing to 11.14% for those with an ASA score of 4. Our study observed a 30-day mortality rate of 3.7% in TBI patients, predominantly those with ASA scores of 3 (ranging from 2 to 4), aligning with these findings. Additionally, we found a strong correlation between ASA score and 90-day mortality in mTBI patients (p < 0.001), independent of age (p = 0.048), indicating its potential as a valuable predictive marker for TBI outcomes.
We did not observe the same independent result of ASA score in our NTBI cohort, despite literature suggesting otherwise. Previous studies have demonstrated a strong association between pre-existing medical conditions and increased in-hospital mortality after trauma [17, 19, 40, 46]. In our study, the deceased NTBI cohort was older than the deceased TBI cohort (86 vs. 77 years, p = 0.043) but had similar ASA score (p = 0.462). NTBI patients were significantly less injured (NISS 10 vs. 22, p < 0.001) yet had a slightly lower TRISS (0.99 vs. 1, p < 0.001). Several possible aspects might explain this difference. Firstly, there might be a treatment bias and under-triaging of mTBI compared to NTBI patients. Research indicates treatment intensity for elderly TBI patients is reduced compared to younger adults, suggesting that a treatment bias [39], and under-triaging [24, 35], exist. Although treatment bias and under-triaging can occur in NTBI patients as well, the nature of treatment for mTBI differs significantly. In our setting, the absence of neurosurgical care compared to readily available trauma and orthopedic surgery means that the threshold for transferring an mTBI patient to a higher level of care is likely higher. This limitation can potentially impact outcomes more significantly in mTBI patients, as delays or omissions in specialized treatment might exacerbate their condition. Secondly, it might be due to inclusion bias as the SweTrau registry excludes isolated hip fractures and thereby the frailest NTBI patients. Thirdly, elderly patients who do not sustain a TBI after a trauma might demonstrate a higher resilience compared to those who do. This hypothesis is strengthened by the fact that TRISS showed a small, but statistically significant difference between the outcome of NTBI and not mTBI. TRISS calculates a survival probability based on anatomical and physiological data and is widely established in trauma research and to measure performance of trauma care systems [11, 32]. Studies have also shown its usefulness in severe TBI [29, 47], and its limited effectiveness in our study indicate that factors beyond the immediate scope of the injury, such as pre-existing health conditions captured by the ASA score, play a more crucial role in determining mortality in mTBI patients. Adding ASA score to TRISS can improve its accuracy in predicting mortality [12], and emphasizes the value of including pre-injury health information in models predicting outcomes, especially in less severe trauma cases.
The TBI cohort had worse GOS scores at discharge compared to NTBI, which likely reflect the older age and higher ASA scores in this group. This finding indicates a greater burden of pre-existing health conditions and may not fully capture the long-term functional outcomes. As GOS scores at discharge primarily reflect acute recovery, they might underestimate the potential for longer-term improvement, especially since no pre-injury GOS scores were available for comparison.
This study has several limitations that warrant consideration. Firstly, the study was conducted at a single level III trauma center, which provided a controlled environment for data collection and analysis but may limit the generalizability of our findings. However, these centers manage a majority of mTBI patients making it a relevant setting for this cohort. Secondly, the majority of the mTBI cohort had intracranial findings, compared to the usual 10% of mTBI patients [27], representing the more severe end of the mTBI spectrum. As the management of complicated mTBI is more complex, this group is highly relevant to study compared to mTBI patients without intracranial findings. Thirdly, the study has a relatively small sample size, with 244 TBI patients included and only 20 events for the primary outcome of 90-day mortality. The mortality rate is aligned with other studies of mTBI [4, 31, 41], and our exclusion rate due to missing data was low, suggesting that our cohort is relevant to typical level III trauma populations. Due to this, however, we have refrained from extensive multivariable analyses which would likely be underpowered and have instead focused on adjusting for only age and ASA, showing an independent association with mortality. Larger, multi-center studies will have to validate if ASA remains independent in presence of other relevant factors such as injury metrics (i.e. AIS). Finally, we selected 90-day mortality rather than 30-day mortality as our primary endpoint to capture the full scope of mortality attributable to TBI. Prior studies indicate that the risk of death may remain elevated beyond 30 days [15, 28, 50]. However, it is important to note that longer follow-up intervals increase the potential for confounding from trauma-unrelated causes of death. Despite this, we believe our findings offer significant insights into the factors affecting outcomes after mTBI. The ASA score, in particular, emerges as a relevant metric for prognostic models, providing additional predictive value beyond age and specific comorbid diagnoses.
Conclusion
This retrospective cohort study highlights a significant association between ASA score and 90-day mortality in elderly patients with complicated mTBI, which is not observed in the NTBI cohort. These findings suggest the benefit of incorporating ASA score into prognostic models to enhance the accuracy of outcome predictions and guide treatment strategies in this vulnerable population.
Data availability
The data that support the findings of this study are available on request from the corresponding author OK. The data are not publicly available due to them containing information that could compromise research participant privacy.
References
Boyd CR, Tolson MA, Copes WS (1987) Evaluating trauma care: the TRISS method. Trauma Score and the Injury Severity Score. J Trauma 27:370–378
Brohi K (2008) The Utstein template for uniform reporting of data following major trauma: a valuable tool for establishing a pan-European dataset. Scand J Trauma Resusc Emerg Med 16:8. https://doi.org/10.1186/1757-7241-16-8
Champion HR, Sacco WJ, Carnazzo AJ, Copes W, Fouty WJ (1981) Trauma score. Crit Care Med 9:672–676. https://doi.org/10.1097/00003246-198109000-00015
Cheng PL, Lin HY, Lee YK, Hsu CY, Lee CC, Su YC (2014) Higher mortality rates among the elderly with mild traumatic brain injury: a nationwide cohort study. Scand J Trauma Resusc Emerg Med 22:7. https://doi.org/10.1186/1757-7241-22-7
Clement ND, Tennant C, Muwanga C (2010) Polytrauma in the elderly: predictors of the cause and time of death. Scand J Trauma Resusc Emerg Med 18:26. https://doi.org/10.1186/1757-7241-18-26
Collaborators MCT, Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S (2008) Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ 336:425–429. https://doi.org/10.1136/bmj.39461.643438.25
Delegates AHo (2020) ASA Physical Status Classification System. https://www.asahq.org/standards-and-practice-parameters/statement-on-asa-physical-status-classification-system. Accessed 13 May 2024
Dell KC, Grossner EC, Staph J, Schatz P, Hillary FG (2021) A Population-Based Study of Pre-Existing Health Conditions in Traumatic Brain Injury. Neurotrauma Rep 2:255–269. https://doi.org/10.1089/neur.2020.0065
Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM, Rosenfeld JV, Park KB (2018) Estimating the global incidence of traumatic brain injury. J Neurosurg 130(4):1080–97. https://doi.org/10.3171/2017.10.JNS17352
Dolejs J, Maresova P (2017) Onset of mortality increase with age and age trajectories of mortality from all diseases in the four Nordic countries. Clin Interv Aging 12:161–173. https://doi.org/10.2147/CIA.S119327
Domingues CA, Coimbra R, Poggetti RS, Nogueira LS, de Sousa RMC (2018) New Trauma and Injury Severity Score (TRISS) adjustments for survival prediction. World J Emerg Surg 13:12. https://doi.org/10.1186/s13017-018-0171-8
Driessen MLS, van Klaveren D, de Jongh MAC, Leenen LPH, Sturms LM (2022) Modification of the TRISS: simple and practical mortality prediction after trauma in an all-inclusive registry. Eur J Trauma Emerg Surg 48:3949–3959. https://doi.org/10.1007/s00068-022-01913-2
Gardner RC, Dams-O’Connor K, Morrissey MR, Manley GT (2018) Geriatric Traumatic Brain Injury: Epidemiology, Outcomes, Knowledge Gaps, and Future Directions. J Neurotrauma 35:889–906. https://doi.org/10.1089/neu.2017.5371
Hackett NJ, De Oliveira GS, Jain UK, Kim JY (2015) ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg 18:184–190. https://doi.org/10.1016/j.ijsu.2015.04.079
Hirji S, McGurk S, Kiehm S, Ejiofor J, Ramirez-Del Val F, Kolkailah AA, Berry N, Sobieszczyk P, Pelletier M, Shah P, O’Gara P, Kaneko T (2020) Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes. JAMA Cardiol 5:156–165. https://doi.org/10.1001/jamacardio.2019.4657
Jacobs B, Beems T, van der Vliet TM, van Vugt AB, Hoedemaekers C, Horn J, Franschman G, Haitsma I, van der Naalt J, Andriessen TM, Borm GF, Vos PE (2013) Outcome prediction in moderate and severe traumatic brain injury: a focus on computed tomography variables. Neurocrit Care 19:79–89. https://doi.org/10.1007/s12028-012-9795-9
Jenkins PC, Dixon BE, Savage SA, Carroll AE, Newgard CD, Tignanelli CJ, Hemmila MR, Timsina L (2021) Comparison of a trauma comorbidity index with other measures of comorbidities to estimate risk of trauma mortality. Acad Emerg Med 28:1150–1159. https://doi.org/10.1111/acem.14270
Katsanos S, Sioutis S, Reppas L, Mitsiokapa E, Tsatsaragkou A, Mastrokalos D, Koulalis D, Mavrogenis AF (2023) What do hip fracture patients die from? Eur J Orthop Surg Traumatol 33:751–757. https://doi.org/10.1007/s00590-022-03250-x
Kirshenbom D, Ben-Zaken Z, Albilya N, Niyibizi E, Bala M (2017) Older Age, Comorbid Illnesses, and Injury Severity Affect Immediate Outcome in Elderly Trauma Patients. J Emerg Trauma Shock 10:146–150. https://doi.org/10.4103/JETS.JETS_62_16
Kiwanuka O, Lassaren P, Thelin EP, Hanell A, Sandblom G, Fagerdahl A, Bostrom L (2023) Long-term health-related quality of life after trauma with and without traumatic brain injury: a prospective cohort study. Sci Rep 13:2986. https://doi.org/10.1038/s41598-023-30082-4
Kuza CM, Matsushima K, Mack WJ, Pham C, Hourany T, Lee J, Tran TD, Dudaryk R, Mulder MB, Escanelle MA, Ogunnaike B, Ahmed MI, Luo X, Eastman A, Imran JB, Melikman E, Minhajuddin A, Feeler A, Urman RD, Salim A, Spencer D, Gabriel V, Ramakrishnan D, Nahmias JT (2019) The role of the American Society of anesthesiologists physical status classification in predicting trauma mortality and outcomes. Am J Surg 218:1143–1151. https://doi.org/10.1016/j.amjsurg.2019.09.019
Langer LK, Alavinia SM, Lawrence DW, Munce SEP, Kam A, Tam A, Ruttan L, Comper P, Bayley MT (2021) Prediction of risk of prolonged post-concussion symptoms: Derivation and validation of the TRICORDRR (Toronto Rehabilitation Institute Concussion Outcome Determination and Rehab Recommendations) score. PLoS Med 18:e1003652. https://doi.org/10.1371/journal.pmed.1003652
Lefevre-Dognin C, Cogne M, Perdrieau V, Granger A, Heslot C, Azouvi P (2021) Definition and epidemiology of mild traumatic brain injury. Neurochirurgie 67:218–221. https://doi.org/10.1016/j.neuchi.2020.02.002
Marrone F, Zavatto L, Allevi M, Di Vitantonio H, Millimaggi DF, Dehcordi SR, Ricci A, Taddei G (2020) Management of Mild Brain Trauma in the Elderly: Literature Review. Asian J Neurosurg 15:809–820. https://doi.org/10.4103/ajns.AJNS_205_20
Mayhew D, Mendonca V, Murthy BVS (2019) A review of ASA physical status - historical perspectives and modern developments. Anaesthesia 74:373–379. https://doi.org/10.1111/anae.14569
Mikolic A, Polinder S, Steyerberg EW, RetelHelmrich IRA, Giacino JT, Maas AIR, van der Naalt J, Voormolen DC, von Steinbuchel N, Wilson L, Lingsma HF, van Klaveren D, Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study P, Investigators (2021) Prediction of Global Functional Outcome and Post-Concussive Symptoms after Mild Traumatic Brain Injury: External Validation of Prognostic Models in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study. J Neurotrauma 38:196–209. https://doi.org/10.1089/neu.2020.7074
Minkkinen M, Iverson GL, Kotilainen AK, Pauniaho SL, Mattila VM, Lehtimaki T, Berghem K, Posti JP, Luoto TM (2019) Prospective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults. J Neurotrauma 36:2904–2912. https://doi.org/10.1089/neu.2018.6351
Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE, Fleming JB, Katz MH (2015) Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg 262:1071–1078. https://doi.org/10.1097/SLA.0000000000001048
Moon JH, Seo BR, Jang JW, Lee JK, Moon HS (2013) Evaluation of probability of survival using trauma and injury severity score method in severe neurotrauma patients. J Korean Neurosurg Soc 54:42–46. https://doi.org/10.3340/jkns.2013.54.1.42
Naylor RM, Henry KA, Peters PA, Bauman MMJ, Lakomkin N, Van Gompel JJ (2022) High Long-Term Mortality Rate in Elderly Patients with Mild Traumatic Brain Injury and Subdural Hematoma due to Ground-Level Fall: Neurosurgery’s Hip Fracture? World Neurosurg 167:e1122–e1127. https://doi.org/10.1016/j.wneu.2022.08.140
Orso D, Furlanis G, Romanelli A, Gheller F, Tecchiolli M, Cominotto F (2024) Risk Factors Analysis for 90-Day Mortality of Adult Patients with Mild Traumatic Brain Injury in an Italian Emergency Department. Geriatrics (Basel) 9(2):23. https://doi.org/10.3390/geriatrics9020023
Penn-Barwell JG, Bishop JRB, Midwinter MJ (2018) Refining the Trauma and Injury Severity Score (TRISS) to Measure the Performance of the UK Combat Casualty Care System. Mil Med 183:e442–e447. https://doi.org/10.1093/milmed/usx039
Ringdal KG, Skaga NO, Steen PA, Hestnes M, Laake P, Jones JM, Lossius HM (2013) Classification of comorbidity in trauma: the reliability of pre-injury ASA physical status classification. Injury 44:29–35. https://doi.org/10.1016/j.injury.2011.12.024
Roohollahi F, Molavi S, Mohammadi M, Mohamadi M, Mohammadi A, Kankam SB, Farahbakhsh F, Moarrefdezfouli A, Peters ME, Albrecht JS, Gardner RC, Rahimi-Movaghar V (2024) Prognostic Value of Frailty for Outcome Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis. J Neurotrauma 41:331–348. https://doi.org/10.1089/neu.2023.0176
Ruge T, Carlsson AC, Hellstrom M, Wihlborg P, Unden J (2020) Is medical urgency of elderly patients with traumatic brain injury underestimated by emergency department triage? Ups J Med Sci 125:58–63. https://doi.org/10.1080/03009734.2019.1706674
Savitsky B, Givon A, Rozenfeld M, Radomislensky I, Peleg K (2016) Traumatic brain injury: It is all about definition. Brain Inj 30:1194–1200. https://doi.org/10.1080/02699052.2016.1187290
Schellenberg M, Arase M, Wong MD, Demetriades D (2023) Mild traumatic brain injury: not always a mild injury. Eur J Trauma Emerg Surg. https://doi.org/10.1007/s00068-023-02365-y
Sheikh HQ, Alnahhal A, Aqil A, Hossain FS (2021) Length of hospital stay following hip fracture and risk of 30 and 90 day mortality in a United Kingdom cohort. Acta Orthop Belg 87:607–617. https://doi.org/10.52628/87.4.05
Skaansar O, Tverdal C, Ronning PA, Skogen K, Brommeland T, Roise O, Aarhus M, Andelic N, Helseth E (2020) Traumatic brain injury-the effects of patient age on treatment intensity and mortality. BMC Neurol 20:376. https://doi.org/10.1186/s12883-020-01943-6
Skaga NO, Eken T, Sovik S, Jones JM, Steen PA (2007) Pre-injury ASA physical status classification is an independent predictor of mortality after trauma. J Trauma 63:972–978. https://doi.org/10.1097/TA.0b013e31804a571c
Susman M, DiRusso SM, Sullivan T, Risucci D, Nealon P, Cuff S, Haider A, Benzil D (2002) Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma 53:219–223. https://doi.org/10.1097/00005373-200208000-00004. (discussion 223-214)
Tang OY, Shao B, Kimata AR, Sastry RA, Wu J, Asaad WF (2022) The Impact of Frailty on Traumatic Brain Injury Outcomes: An Analysis of 691 821 Nationwide Cases. Neurosurgery 91:808–820. https://doi.org/10.1227/neu.0000000000002116
Team RC (2022) R.
Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale Lancet 2:81–84. https://doi.org/10.1016/s0140-6736(74)91639-0
van der Naalt J, Timmerman ME, de Koning ME, van der Horn HJ, Scheenen ME, Jacobs B, Hageman G, Yilmaz T, Roks G, Spikman JM (2017) Early predictors of outcome after mild traumatic brain injury (UPFRONT): an observational cohort study. Lancet Neurol 16:532–540. https://doi.org/10.1016/S1474-4422(17)30117-5
Wang CY, Chen YC, Chien TH, Chang HY, Chen YH, Chien CY, Huang TS (2018) Impact of comorbidities on the prognoses of trauma patients: Analysis of a hospital-based trauma registry database. PLoS ONE 13:e0194749. https://doi.org/10.1371/journal.pone.0194749
Wong GK, Teoh J, Yeung J, Chan E, Siu E, Woo P, Rainer T, Poon WS (2013) Outcomes of traumatic brain injury in Hong Kong: validation with the TRISS, CRASH, and IMPACT models. J Clin Neurosci 20:1693–1696. https://doi.org/10.1016/j.jocn.2012.12.032
Xiong C, Hanafy S, Chan V, Hu ZJ, Sutton M, Escobar M, Colantonio A, Mollayeva T (2019) Comorbidity in adults with traumatic brain injury and all-cause mortality: a systematic review. BMJ Open 9:e029072. https://doi.org/10.1136/bmjopen-2019-029072
Yue JK, Cnossen MC, Winkler EA, Deng H, Phelps RRL, Coss NA, Sharma S, Robinson CK, Suen CG, Vassar MJ, Schnyer DM, Puccio AM, Gardner RC, Yuh EL, Mukherjee P, Valadka AB, Okonkwo DO, Lingsma HF, Manley GT, Investigators T-T (2019) Pre-injury Comorbidities Are Associated With Functional Impairment and Post-concussive Symptoms at 3- and 6-Months After Mild Traumatic Brain Injury: A TRACK-TBI Study. Front Neurol 10:343. https://doi.org/10.3389/fneur.2019.00343
Zogg CK, Cooper Z, Peduzzi P, Falvey JR, Castillo-Angeles M, Kodadek LM, Staudenmayer KL, Davis KA, Tinetti ME, Lichtman JH (2023) Changes in Older Adult Trauma Quality When Evaluated Using Longer-Term Outcomes vs In-Hospital Mortality. JAMA Surg 158:e234856. https://doi.org/10.1001/jamasurg.2023.4856
Acknowledgements
Thank to Lena Jansson, the Trauma Coordinator at Södersjukhuset for the work with the local registry of SweTrau.
Funding
Open access funding provided by Karolinska Institute. EPT acknowledges funding support from Karolinska Institutet Research Grants (#2022–01576), Region Stockholm ALF (#FoUI-962566), The Swedish Society of Medicine (#SLS-985504), The Swedish Brain Foundation (Hjärnfonden, #FO2023-0124), Region Stockholm Clinical Research Appointment (#FoUI-981490) and the Erling-Persson Family Foundation. The funders did not participate in the design or conduct of the study.
Author information
Authors and Affiliations
Contributions
Study design was performed by all authors. OK was responsible for data collection. Data analyses were performed by OK, PL, and EPT. The first draft of the manuscript was written by OK, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The research protocol was approved by the Swedish Ethical Review Authority (Dnr: 2019–06122).
Consent of publication
Not applicable.
Competing interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kiwanuka, O., Lassarén, P., Hånell, A. et al. ASA-score is associated with 90-day mortality after complicated mild traumatic brain injury – a retrospective cohort study. Acta Neurochir 166, 363 (2024). https://doi.org/10.1007/s00701-024-06247-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00701-024-06247-z